Monday, November 28, 2016

FDA Warns of Dangers From Testosterone Supplements

The US Food and Drug Administration (FDA) has approved class-wide labeling changes for all prescription testosterone products, the agency announced . New safety information from published literature and case reports on the risks associated with abuse and dependence of testosterone and other anabolic androgenic steroids (AAS) will be added to all product labels, the FDA […]

No comments:

Post a Comment